|Year : 2015 | Volume
| Issue : 3 | Page : 334-339
The relationship between different fatty acids intake and frequency of migraine attacks
Omid Sadeghi1, Zahra Maghsoudi1, Fariborz Khorvash2, Reza Ghiasvand1, Gholamreza Askari1
1 Department of Community Nutrition, Food Security Research Center, School of Nutrition and Food Science, Isfahan University of Medical Sciences, Isfahan, Iran
2 Neurology Research Center, Isfahan University of Medical Science, Isfahan, Iran
|Date of Submission||02-Jan-2014|
|Date of Acceptance||06-Dec-2014|
|Date of Web Publication||29-May-2015|
Dr. Gholamreza Askari
Department of Community Nutrition, Food Security Research Center, School of Nutrition and Food Science, Isfahan University of Medical Sciences, Isfahan
Source of Support: Food Security Research Center and Department
of Community Nutrition, School of Nutrition and Food Science, Isfahan
University of Medical Sciences, Isfahan, Iran, Conflict of Interest: None
Background: Migraine is a primary headache disorder that affects the neurovascular system. Recent studies have shown that consumption of some fatty acids such as omega-3 fatty acids improves migraine symptoms. The aim of the present study is to assess the association between usual intake of fatty acids such as eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), and saturated fatty acids (SFA) with the frequency of migraine attacks.
Materials and Methods: 105 migraine patients with age ranging from 15 to 50 years participated in this cross-sectional study. Usual dietary consumption was assessed by using a semi-quantitative food frequency questionnaire (FFQ). Moreover, frequency of migraine attacks during 1 month period was determined in all participants. Data had been analyzed using independent sample t-test and linear regression test with adjustment of confounding variables.
Results: In this study, we found that lower intake of EPA (β = −335.07, P = 0.006) and DHA (β = −142.51, P = 0.001) was associated with higher frequency of migraine attacks. In addition, we observed similar relationship either in men or women. No significant association was found between dietary intake of SFA and the frequency of migraine attacks (β = −0.032, P = 0.85).
Conclusions: Frequency of migraine attacks was negatively associated with dietary intake of omega-3 polyunsaturated fatty acids. No significant relationship was found between SFA intake and migraine frequency. Further studies are required to shed light on our findings.
Keywords: Docosahexaenoic acid, eicosapentaenoic acid, fatty acids, migraine
|How to cite this article:|
Sadeghi O, Maghsoudi Z, Khorvash F, Ghiasvand R, Askari G. The relationship between different fatty acids intake and frequency of migraine attacks. Iranian J Nursing Midwifery Res 2015;20:334-9
|How to cite this URL:|
Sadeghi O, Maghsoudi Z, Khorvash F, Ghiasvand R, Askari G. The relationship between different fatty acids intake and frequency of migraine attacks. Iranian J Nursing Midwifery Res [serial online] 2015 [cited 2021 Oct 15];20:334-9. Available from: https://www.ijnmrjournal.net/text.asp?2015/20/3/334/157831
| Introduction|| |
Migraine disorder, in addition to being tension-type headache, is known as a progressive and prevalent paroxysmal neurological disorder that can affect nearly 80% of people all over the world.  Migraine risk is three times more prevalent in women than men.  Its common symptoms are severe headache which accompany with neck pain, muscle tension, and nausea; in several migraine attacks, patients may experience photophobia and phonophobia symptoms. , The clinical and subclinical symptoms of migraine as a neurovascular disorder occur following the production of producing pro-inflammatory factors around the nerves and in the blood vessels of the head.  This disturbance can lead to twofold higher risk for ischemic stroke.  Studies reflect that individuals with migraine attacks are more prone to epilepsy, atopic diseases, inflammatory and degenerative disorders, and cardiovascular diseases.  Migraine attack is a multi-factorial disorder which can be affected by several genetic, acquired, and environmental factors.  It seems managing individuals' lifestyle, such as physical activity, dietary intake, and environmental stress, can be useful to control migraine attacks. ,,,, Very long-chain n-3 polyunsaturated fatty acids
Migraine is an inflammatory disease and we can use the anti-inflammatory roles of micronutrients for its treatment.  Long-chain n-3 polyunsaturated fatty acids (PUFAs) including eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are the major anti-inflammatory micronutrients that seem to reduce the effects of migraine. ,, The balance between these pro- and anti-inflammatory nutrients can be related with various symptoms and outcomes of migraine attacks such as severity, frequency, and other related indices. , Due to the growing recommendation in usage of omega-3 fatty acids in recent years, confirming the useful effects of these nutrients in managing migraine outcomes can be a proper strategy in nursing care. Some studies reported that intake of long-chain n-3 PUFAs has beneficial effects on migraine attacks frequency, , but one study did not show any significant effect.  Therefore, findings in this regard are inconsistent and studies are mainly focused on the effects of long-chain n-3 PUFA supplements. The present study was conducted with the aim of assessing the association between various types of fatty acids including dietary EPA, DHA, and saturated fatty acids (SFA) with the frequency of migraine attacks.
| Materials and Methods|| |
This cross-sectional study was conducted on 117 individuals (25 men and 92 women) with age ranging from 15 to 50 years. Migraine was diagnosed by a neurologist according to the International Headache Society (IHS) criteria.  Inclusion criteria were having a history of migraine for a long time (>5 years) and having 1 year history of severe, recurrent, and long-lasting migraine attacks (at least one attack per month lasting 4 h). Frequency of migraine attacks during 1 month period was determined in all participants by the neurologist. Patients should answer this question, "How many migraine attacks do you have per month?" High frequency of migraine attacks is defined as having more than 10 attacks per month.  Patients with tension-type headache and chronic pain were excluded from the study. After explaining the process and aims of the study, participants were asked to sign a written consent. The ethical committee of Isfahan University of Medical Sciences (IUMS), Isfahan, Iran approved our study.
Usual dietary consumption was assessed by using a 168-item semi-quantitative food frequency questionnaire (FFQ). , This questionnaire consisted of 17 food groups and every food group contained several food items in addition to standard portion size for each food (Willett format)  [Table 1]. This questionnaire had almost all the fat-containing foods in Iranian dietary pattern. The questionnaires were completed in a face-to-face interview by an educated dietitian with at least 3 years of experience in the food consumption survey. Participants were asked to reporttheir dietary intake of foods based on questions with nine choices as follows: never or less than once per month, 1-3 times per month, 1 time per week, 2-4 times per week, 5-6 times per week, 1 time per day, 2-3 times per day, 4-5 times per day, 6 or more times per day." We computed daily intake of all food items and then converted it to grams per day using household measures. Each food and beverage was analyzed for the content of energy and fatty acids using NUTRITIONIST III software (version 7.0; N-Squared Computing, Salem, OR, USA), which was designed for evaluation of Iranian foods. , Reliability and validation of the mentioned FFQ were checked in a previous study. 
|Table 1: Food groups, food items, and standard portion size of each food in FFQ |
Click here to view
All quantitative variables are presented as mean and standard deviation [Table 1]. Data were compared between men and women by using independent sample t-test. To assess the association between dietary intake of fatty acids and the frequency of migraine attacks, we used linear regression in crude and three adjusted models for dietary intake, age, and body mass index (BMI). All data analysis was performed using SPSS software (version 18.0; SPSS, Inc., Chicago, IL, USA). Significant levels were set as P value less than 0.05.
| Results|| |
We had complete data about a total of 105 subjects (23 men and 82 women) with a mean age of 32.30 ± 9.66 years, and 12 individuals refused to participate. Mean dietary intake of energy, SFA, EPA, and DHA, in addition to age, BMI, and frequency of migraine attacks in the entire study population as well as in men and women separately are shown in [Table 2]. [Table 3] reveals the differences between patients with moderate and high frequency of migraine attacks in their dietary intake of fatty acids. Migraine patients with high frequency of migraine attacks had lower dietary intake of EPA and DHA in crude or energy-adjusted form and higher BMI, compared to patients with moderate frequency of migraine attacks. No significant differences were found between patients with moderate and high frequency of attacks in age, dietary intake of energy and SFA, either in crude or energy-adjusted form.
|Table 3: Dietary intake of fatty acids in patients with moderate and high frequency of migraine attacks† |
Click here to view
[Table 4] presents the results of multiple linear regression analysis for the association between dietary intake of SFA, EPA, and DHA with the frequency of migraine attacks. There was a significant negative association between EPA and DHA intake with migraine attack frequency. This relationship remained significant even after adjustment of energy, age, and BMI. No significant relationship was found between dietary intake of SFA and frequency of migraine attacks, either in crude or confounding variable adjusted models.
|Table 4: Association between dietary intake of fatty acids and frequency of migraine attacks† |
Click here to view
Results of sex-stratified analysis for the association between dietary intake of fatty acids and frequency of migraine attacks are shown in [Table 5]. Among men, a significant negative association was found between EPA and DHA consumption with the frequency of migraine attacks. However, this relationship attenuated after adjustment of potential confounding variables. Among women, dietary intake of EPA and DHA was negatively associated with the frequency of migraine attacks. Controlling for confounders showed no changes in this relationship. No significant association was found between dietary intake of SFA and frequency of migraine attacks, either in men or women.
|Table 5: Association between dietary intake of fatty acids and frequency of migraine attacks among men and women† |
Click here to view
| Discussion|| |
In this study, we aimed to assess the association between usual intake of fatty acids including SFA, EPA, and DPA and the frequency of migraine attacks. We found that lower intake of EPA and DHA was associated with higher frequency of migraine attacks. This relationship remained significant even after adjustment of potential confounding variables. In addition, such relationship was observed either in men or women. No significant association was found between dietary intake of SFA and frequency of migraine attacks either in crude and adjusted model. This is one of the few studies that examined the association between usual consumption of fatty acids and migraine symptoms.
Although some studies have demonstrated that fatty acids may affect migraine symptoms, data on the association between usual consumption of fatty acids and migraine are scarce. Earlier studies have mostly focused on the use of high doses of fatty acids, especially PUFAs.  These studies have shown that high doses of omega-3 PUFAs have beneficial effects on migraine symptoms, especially the frequency of migraine attacks. 
In this study, higher consumption of omega-3 PUFAs such as DHA and EPA was associated with lower frequency of migraine attacks. In line with our findings, Harel et al. reported that administration of fish oil rich in very long-chain n-3 PUFAs reduced the frequency of migraine attacks.  In an open-label uncontrolled study, consumption of gamma-linolenic and alpha-linolenic acids decreased the frequency of migraine attacks.  In contrast, Pradalier et al. reported that consumption of omega-3 PUFAs had no effect on the frequency of migraine attacks.  Inconsistent results obtained in different studies may be due to the differences in subjects' genetic polymorphism, physical activity level, and their health status.
The exact mechanism through which omega-3 PUFAs might affect the frequency of migraine remains unknown. However, migraine is affected by inflammatory factors and studies have shown that omega-3 PUFAs can decrease the inflammation status.  Omega-3 PUFAs can reduce the production of nitric oxide which is believed to play a role in the occurrence of migraine attacks.  Moreover, several studies have shown a possible link between n-3 PUFAs and serotonin, so its effects on serotonin level can explain the etiology of migraine.  Confirming the effects of omega-3 PUFAs can be useful in nursing care and in the process of reducing bothersome migraine attacks.
The present study has some limitations. The first one is the cross-sectional nature of our study; hence, we cannot establish a causal link between omega-3 PUFA consumption and the frequency of migraine attacks. Further studies are needed to confirm our findings. Second, the sample size of our study was small and more studies with larger participant number are required. Third, despite several adjustments, further control for confounding variables such as genetic polymorphism and psychosocial factors will be needed to reach an independent association between omega-3 PUFA consumption and migraine frequency.
| Conclusion|| |
Frequency of migraine attacks was negatively associated with dietary intake of omega-3 PUFAs. This relationship remained significant even after adjustment of potential confounding variables. No significant relationship was found between SFA intake and migraine frequency either in crude or adjusted model. Further studies are required to shed light on our findings.
| Acknowledgments|| |
We thank all the participants of the study. This study has been obtained from the Food Security Research Center and Department of Community Nutrition, School of Nutrition and Food Science, Isfahan University of Medical Sciences, Isfahan, Iran. This article was derived from a master thesis of (Omid Sadeghi) with project number 392363 Isfahan University of Medical Sciences, Isfahan, Iran
| References|| |
Yoon MS, Katsarava Z, Obermann M, Fritsche G, Oezyurt M, Kaesewinkel K, et al
. Prevalence of primary headaches in Germany: Results of the German Headache Consortium Study. J Headache Pain 2012;13:215-23.
Steiner TJ. Lifting The Burden: The Global Campaign to Reduce the Burden of Headache Worldwide. Aids for management of common headache disorders in primary care. J Headache Pain 2007;8:S26-9.
Sadeghi O, Maghsoudi Z, Nasiri M, Khorvash F, Askari G. The Association between Anthropometric Measurements and Severity, Frequency and Duration of Headache Attacks in Adults with Migraine in Isfahan. J Mazandaran Univ Med Sci 2014;24:194-203.
Unalp A, Dirik E, Kurul S. Prevalence and clinical findings of migraine and tension-type headache in adolescents. Pediatr Int 2007;49:943-9.
Schürks M. Genetics of migraine in the age of genome-wide association studies. J Headache Pain 2012;13:1-9.
Lateef TM, Cui L, Nelson KB, Nakamura EF, Merikangas KR. Physical Comorbidity of Migraine and Other Headaches in US Adolescents. J Pediatr 2012;161:308-13.
Kowa H, Yasui K, Takeshima T, Urakami K, Sakai F, Nakashima K. The homozygous C677T mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for migraine. Am J Med Genet 2000;96:762-4.
Panconesi A. Alcohol and migraine: Trigger factor, consumption, mechanisms. A review. J Headache Pain 2008;9:19-27.
Spierings EL, Ranke AH, Honkoop PC. Precipitating and aggravating factors of migraine versus tension-type headache. Headache 2001;41:554-8.
Raggi A, Giovannetti AM, Quintas R, D′Amico D, Cieza A, Sabariego C, et al
. A systematic review of the psychosocial difficulties relevant to patients with migraine. J Headache Pain 2012;13:595-606.
Camboim Rockett F, Castro K, Rossoni de Oliveira V, da Silveira Perla A, Fagundes Chaves ML, Schweigert Perry ID. Perceived migraine triggers: Do dietary factors play a role? Nutr Hosp 2012;27:483-9.
Mauskop A. Nonmedication, alternative, and complementary treatments for migraine. Continuum 2012;18:796-806.
Yan Y, Jiang W, Spinetti T, Tardivel A, Castillo R, Bourquin C, et al
. Omega-3 fatty acids prevent inflammation and metabolic disorder through inhibition of NLRP3 inflammasome activation. Immunity 2013;38:1154-63.
Xu QH, Cai GL, Lu XC, Hu CB, Chen J, Yan J. The effects of omega-3 fish oil lipid emulsion on inflammation-immune response and organ function in patients with severe acute pancreatitis. Chinese J Inter Med 2012;51:962-5.
Wagner W, Nootbaar-Wagner U. Prophylactic treatment of migraine with gamma-linolenic and alpha-linolenic acids. Cephalalgia 1997;17:127-30.
Harel Z, Gascon G, Riggs S, Vaz R, Brown W, Exil G. Supplementation with omega-3 polyunsaturated fatty acids in the management of recurrent migraines in adolescents. J Adolesc Health 2002;31:154-61.
Pradalier A, Bakouche P, Baudesson G, Delage A, Cornaille-Lafage G, Launay JM, et al
. Failure of omega-3 polyunsaturated fatty acids in prevention of migraine: A double-blind study versus placebo. Cephalalgia 2001;21:818-22.
Olesen J. The International Classification of Headache Disorders. 2 nd
ed. Cephalalgia, Spain 2004;24:9-160.
Stewart WF, Lipton RB, Dowson AJ, Sawyer J. Development and testing of the Migraine Disability Assessment (MIDAS) questionnaire to assess headache related disability. Neurology 2001;56:S20-8.
Esmaillzadeh A, Mirmiran P, Azizi F. Whole-grain intake and the prevalence of hyperglyceridemic waiste phenotype in Tehranian adults. Am J Clin Nutr 2005;81:55-63.
Esfahani FH, Asghari G, Mirmiran P, Azizi F. Reproducibility and relative validity of food group intake in a food frequency questionnaire developed for the Tehran Lipid and Glucose Study. J Epidemiol 2010;20:150-8.
Rimm EB, Giovannucci EL, Stampfer MJ, Colditz GA, Litin LB, Willett WC. Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals. Am J Epidemiol 1992;135:1114-26.
Kimiagar SM, Ghaffarpour M, Houshiar-Rad A, Hormozdyari H, Zellipour L. Food consumption pattern in the Islamic Republic of Iran and its relation to coronary heart disease. East Mediterr Health J 1998;4:539-47.
Ghaffarpour M, Houshiar-Rad A, Kianfar H. The manual for household measures, cooking yields factors and edible portion of foods. Tehran, Iran: Keshavarzi Press; 1999. p. 1-46.
Jeyarajah DR, Kielar M, Penfield J, Lu CY. Docosahexaenoic acid, a component of fish oil, inhibits nitric oxide production in vitro
. J Surg Res 1999;83:147-50.
Hibbeln JR, Linnoila M, Umhau JC, Rawlings R, George DT, Salem N Jr. Essential fatty acids predict metabolites of serotonin and dopamine in cerebrospinal fluid among healthy control subjects, and early- and late-onset alcoholics. Biol Psychiatry 1998;44:235-42.
[Table 1], [Table 2], [Table 3], [Table 4], [Table 5]